Oscar Health (NYSE:OSCR) Now Covered by Jefferies Financial Group

Jefferies Financial Group assumed coverage on shares of Oscar Health (NYSE:OSCR) in a report issued on Tuesday morning, MarketBeat.com reports. The brokerage issued an underperform rating and a $12.00 price objective on the stock.

OSCR has been the topic of a number of other reports. UBS Group initiated coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Finally, Piper Sandler reissued an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $21.56.

Oscar Health Trading Down 9.2 %

Oscar Health stock opened at $15.02 on Tuesday. The stock has a market cap of $3.71 billion, a PE ratio of -259.17 and a beta of 1.64. The stock has a 50-day moving average price of $16.80 and a 200 day moving average price of $17.77. Oscar Health has a 52 week low of $7.50 and a 52 week high of $23.79. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. During the same quarter in the previous year, the firm posted ($0.29) EPS. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. Equities research analysts predict that Oscar Health will post -0.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, COO Steven Wolin sold 19,580 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the completion of the sale, the chief operating officer now owns 102,598 shares in the company, valued at $1,854,971.84. The trade was a 16.03 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The stock was bought at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. The trade was a 5.80 % increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Oscar Health

Large investors have recently modified their holdings of the business. Simplicity Wealth LLC acquired a new position in shares of Oscar Health during the second quarter worth about $179,000. SG Americas Securities LLC boosted its position in shares of Oscar Health by 900.6% during the second quarter. SG Americas Securities LLC now owns 190,039 shares of the company’s stock worth $3,006,000 after buying an additional 171,047 shares during the period. Assenagon Asset Management S.A. boosted its position in shares of Oscar Health by 32.9% during the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after buying an additional 507,009 shares during the period. Raymond James & Associates acquired a new position in shares of Oscar Health during the second quarter worth about $3,168,000. Finally, Hennessy Advisors Inc. acquired a new position in shares of Oscar Health during the second quarter worth about $9,047,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.